4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-002942
Options or other derivatives
- President and COO acquired 336,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Davis Hugh M. President and COO | 2025-02-03 | Grant or award · Restricted Stock Units | +74,700 | 74,700 | D | ||
| Davis Hugh M. President and COO | 2025-02-03 | Grant or award · Employee Stock Option (Right to Buy) | +261,600 | 261,600 | D | ||
Loading xslF345X05/form4-02042025_040211.xml…